Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Adds Genentech, Gilead To Its Ranks Ahead Of House Democrats’ Drug Pricing Scrutiny

Executive Summary

Roche, through Genentech, returns to the PhRMA fold after leaving the trade group in 2009; Gilead is a first-time member; both are retaining their BIO memberships as well.

Advertisement

Related Content

Insulin Makers May Be First In Crosshairs Of DeGette Rx Pricing Investigation
House Oversight Drug Pricing Hearings Will Begin With Expert, Patient Witnesses
Democrats’ Drug Pricing Bills Echo Trump Ideas But Broad Republican Support Unlikely
Drug Pricing In The Next Senate: Incoming Finance Chair Grassley Outlines Priorities
Gilead Lowering HCV Drug List Prices With Authorized Generics
Putting The 'Big' Back In PhRMA: New Membership Criteria Pares Ranks

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124590

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel